Please assess the completion status of the following clinical trial:

Trial Title: Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Italian citizens, residing in the Region~* Registered as beneficiaries for at least one year between January 1st, 2012 and September 30th, 2018~* Diagnosis of type 2 diabetes~* Newly initiating SGLT-2 inhibitors or GLP-1 receptor agonists~* Being treated with glucose lowering medications before (at least one prescription of an antidiabetic agent in ATC class A10B prior to the index date)~* Time between the index date and the last SGLT2 inhibitors or GLP-1 receptor agonists prescription shorter than 8 months,~* Follow-up time or time-to-endpoint of at least three months~Exclusion Criteria:~* Patients who started SGLT2i or GLP-1RA before 2014~* Patients with an insufficient exposure time~* Patients with an incident event within three months after the index date.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: None

Study Arms:
- SGLT2i (Type: None): Patients who received new prescription of a SGLT-2 inhibitor
- GLP-1RA (Type: None): Patients who received new prescription of a GLP-1 receptor agonist

Based on this trial design, predict the completion outcome and termination type (if applicable).